Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, WOM, TRI

New Study Published in MDPI Demonstrates Combination of Virtual Reality and Artificial Intelligence Reduces Hot Flashes and Improves Psychological Well-Being in Women

Study Utilized XRHealth's VR-AI Technology on Women with Breast and Ovarian Cancer

BOSTON, Nov. 30, 2022 /PRNewswire/ --The results of a clinical trial using software from XRHealth, developer and operator of virtual treatment rooms in the metaverse, published in MDPI highlights that the combination of virtual reality and artificial intelligence reduces hot flashes and improves the overall psychological well-being of women with breast and ovarian cancer. 

According to the CDC, each year in the United States alone 264,000 women are diagnosed with breast cancer and the American Cancer Society predicts that in 2022 19,880 women will be diagnosed with ovarian cancer. Female cancer survivors often experience hot flashes that can also cause difficulty sleeping and waking up with night sweats.

The study consisted of forty-two women, ranging in ages 25-60 that suffered from hot flashes and were receiving chemotherapy, endocrine therapy, or estrogen blocking anticancer treatment. The patients used XRHealth VR-AI based technology consistently for 24 consecutive days, utilizing both the cognitive behavioral therapy and mindfulness-based stress reduction that took place in a virtual winter wonderland setting. Patients were asked to self-report and assess hot flashes, psychiatric distress, illness perception, quality of sleep, and quality of life. Patients reported a significant reduction in the frequency of hot flashes, stress, psychiatric distress, sleep difficulties, and quality of life. The results demonstrated that VR-AI technology can markedly alleviate hot flashes and mental health conditions with those coping with breast and ovarian cancer. The study also highlighted the mind-body connection and the impact that it has on physical symptoms.

Some results from the study include:

"The combination of virtual reality and artificial intelligence technology is making a profound impact on healthcare treatments by working with the mind to alleviate bodily symptoms," says Eran Orr, CEO of XRHealth. "Through our extensive research, we are demonstrating the effectiveness of XR virtual therapy on patients with a myriad of conditions including breast and ovarian cancer."

The XRHealth platform enables clinicians to view and access data regarding patient progress so that healthcare outcomes are tangible and measured clinically as well as reported by patients. Patient therapy in a virtual environment can be measured more accurately than in a brick-and-mortar setting since the technology is able to capture and track unique insights.

About XRHealth

XRHealth is revolutionizing healthcare, bringing patient care into the Metaverse. The company operates state-of-the-art therapeutic care Virtual Rooms, utilizing proprietary FDA and CE registered medical Extended Reality (XR) technology (virtual and augmented reality). XRHealth integrates immersive XR technology, licensed clinicians, and advanced data analytics on one platform, providing a comprehensive therapeutic care solution for patients to receive treatment from the comfort of their home. The company offers a variety of patent-pending solutions from rehabilitation services to cognitive assessment and training to pain management. XRHealth works with several world-renowned U.S. healthcare providers, hospitals, and rehabilitation centers. Founded in 2016, XRHealth is headquartered in Boston, Massachusetts and its R&D center is located in Tel-Aviv, Israel. For more information, visit https://www.xr.health/

DeeDee Rudenstein,
[email protected],
(267) 521-9654


These press releases may also interest you

at 09:16
A latest research report [115+] pages with 360-Degree visibility, titled "Attention Deficit Hyperactivity Disorder Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Stimulants, and Non-Stimulants); By Demographics; By Distribution...

at 09:15
Know Labs, Inc. , an emerging developer of non-invasive medical diagnostic technology, today shared an update on its strategic partnerships with leading experts in data science, sensor technology, product design and regulatory affairs. These...

at 09:15
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing multiple therapeutic platforms intended to enhance Treg function, including biologics and cell therapies, today announced plans for presenting...

at 09:15
Dr. Steven Gundry, a world-renowned heart surgeon, is the creator of the revolutionary supplement brand Gundry MD. Their best-selling product Gundry MD® Total Restore® has sold over 2 million units in the year 2022. This one-of-a-kind dietary...

at 09:15
This cold and flu season, Puffs tissues is once again bringing our Puffs Power Pals together with the actress, Dominique Thorne, to lend a soft touch to the world's fiercest superheroes at Children's Healthcare of Atlanta. For those children battling...

at 09:10
PharmaCyte Biotech, Inc. ("PharmaCyte" or the "Company"), a biotechnology company focused on evaluating its signature live-cell encapsulation technology, Cell-in-a-Box® for potential development of cellular therapies for cancer, diabetes and...

News published on 30 november 2022 at 07:00 and distributed by: